Lonza erzielt fĂŒr 2024 ein solides Ergebnis mit konstantem ...
Lonza Delivers Solid 2024 Performance with CER Sales in ...
Lonza Investor Update 2024 Outlines Strategy New Organizational ...
Lonza to Expand Bioconjugation in Visp (CH) with Two Additional ...
Q3 2024 Qualitative Update: Lonza Confirms Full-Year Outlook ...
Lonza Extends Collaboration with Major Pharmaceutical Partner ...
Lonza Nominates David Meline as Independent Board Member ...
Lonza Completes Acquisition of Large-Scale Biologics Site ...
Lonza and Vertex Sign a Long-Term Commercial Supply Agreement ...
Lonza Prices EUR 1.2 Billion Dual-Tranche Straight Bonds ...
Lonza Nominates Juan Andres and Eric Drapé as Independent ...
2024 Halbjahresperformance der Lonza Gruppe in Ăbereinstimmung ...
Lonza Group H1 2024 Performance Well On Track to Deliver ...
Lonza Welcomes New Group Chief Executive Officer Wolfgang ...
Q1 2024 Qualitative Update:Â Performance In Line with Expectations ...
Lonza Announces Results of the 2024 Annual General Meeting ...
Lonza gibt Ergebnisse der Generalversammlung 2024 bekannt ...
Lonza Prices EUR 1 Billion Straight Bond with a 3.875% Coupon ...
Lonza Publishes Invitation to the 2024 Annual General Meeting ...
Lonza ernennt Wolfgang Wienand zum neuen Chief Executive ...
Lonza Appoints Wolfgang Wienand as New Chief Executive Officer ...
Lonza Signs Agreement to Acquire Large-Scale Biologics Site ...
Jean-Marc Huët to succeed Albert M. Baehny as Chairman ...
Lonza erzielt im 2023 ein solides Ergebnis mit 10.9% (kWk) ...
Lonza Prices CHF 400 Million Dual-Tranche Straight Bonds ...